Pharvaris GmbH

About Pharvaris GmbH

Pharvaris GmbH is a Nasdaq listed late-stage biotech company focused on developing bradykinin B2 receptor antagonists for treating bradykinin-mediated diseases, particularly Hereditary Angioedema (HAE). The company operates offices in Switzerland, the Netherlands, and the greater Boston area in the U.S.A., aiming to provide new therapeutic options for patients suffering from life-threatening swelling attacks.

Career Opportunities

Pharvaris GmbH offers a dynamic working environment where employees can contribute to meaningful advancements in healthcare. The company values diversity of thought and encourages professional growth through collaboration and innovation.

• Hybrid work options available
• Commitment to employee development
• Culture built on trust and rigor